Eli Lilly and Company 13D and 13G filings for Sigilon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:33 pm Purchase | 2023-06-28 | 13D | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 1,008,830 40.300% | 797,719 (+377.87%) | Filing |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 211,111 8.800% | 211,111 (New Position) | Filing |